
AACR 2016: New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations
The new investigational anticancer therapeutic BGB-283, which targets the RAF family of proteins, was safe,…
The new investigational anticancer therapeutic BGB-283, which targets the RAF family of proteins, was safe,…